Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
FFS I want to go with my best analysis and 90% SURE instinct because I've been tracking AMRN off and on for the last 4 years. That's all.
Kiwi Yes, my current AMRN position is short. You should be able to make $$ in both BEAR & BULL trends. If you know almost %90 SURE (according to your analysis & instinct) that SP will go down you owe it to yourself that you must take advantage of it to make some $$. ALL tutes will do the same thing in addition to options and so should all retail investors/traders. AND as I expected $1.47 close 2day. Let's see how low AH will be.
FULL DISCLOSURE I sold all my shares & shorted additional shares this morning. I think my chance to buy to cover & go long is rather positive today. BUT I'm not going to buy YET. IF SP is sinking to $1.47 (yesterday LOW) and no support I'm quite positive that you can buy AMRN at lower cost (average DOWN) if you wait. GLTA Longs & Shorts!!
2day is definitely a RED DAY for AMRN. In addition, there are 5M+ shares available to short with only %.875 annual interest. SP may get 10% haircut 2day. That's how I see it.
Kiwi Not necessarily Depending on VOLUME, intraday SP oscillation rate, timing, some market sentiment, my own instinct, and...LOTS OF LUCK I may sell, sell short, buy to cover, and buy during 2 trading days.
kiwi I'm 110% in agreement with your "....this is IMHO a probability game". Don't be so surprised if 2morrow SP may turn RED. Why? The probability for the 5th GREEN day in a row is VERY LOW. If you look at AMRN 1-year trading chart, AMRN SP with 5-day-in-a-row GREEN happened only twice: 8/2/21 - 8/6/21 and 3/31/22 - 4/6/22. It's already RED now AH. I'm looking at 2morrow and the next day for my swing trade even I'm in the GREEN right now. Best LUCK to you!!
I'm GLAD you're inspired. Go ahead and try it. Very BEST luck to you!!
Kiwi I understand your FA reasoning BUT SP was $1.11 (new 52-week low) just last week. For short term traders FA has almost ZERO/NADA value. JMHO!
jasbg the only way to "win" with AMRN is TRADING it. AMRN usually/mostly DOES NOT stay GREEN 4 or 5 days in a row. 2day will be 4th GREEN day. I'm not a day trader BUT I swing it as often as I can. I ALWAYS sell AMRN whenever its intraday UP more than 10%. I'll wait couple more days b4 I may sell or buy some more. GLTU!
My only concern is there are Millions shares available to short with only %.75 interest. I'll be happy if AMRN closes 2day $1.62+ and stays GREEN this week. LOL!!
I turned LONG with 40K shares at $1.52 average. Attached is the latest BUYING Tutes during Q1 22 (ended 3/31/22). Sarissa's shares is the same 24Mil (in Jan 2022) as filed today. Here's some major buyers - GS actually increased its share %82.35, Two Sigma Investment %106.0, Fairmount Fund %65.45, Citadel Advisors %101.42 ... Enjoy!
I hope some of AMRN longs bought SOME $EJH yesterday. EJH is up 27%+ PM. Check it out! Keep toes&fingers CROSSED! DON'T SET STOP LOSS! GLTA Longs!
When it rains it POURS. There are now SIX (6) class action law suits FILED AGAINST AMRN. What the F!CK is going on and WHY? https://finance.yahoo.com/quote/AMRN/ ... This just kills all longs dream of BO. Which BP will be STUPID ENOUGH to even explore AMRN BO. Time to move on to VERY HIGH POTENTIAL small cap to regain all your AMRN loss & actually make $. I'm highly encouraging all losing AMRN longs to look at a very small cap $EJH Chinese company that has been actually profitable YoY with REV GROWTH YoY (except covid-19 2020). EJH spent almost 2.5 years (started on 3/14/19) for the filing & registration with the SEC b4 it could start its $4.50 IPO on 5/14/21. During the 2.5 year, the SEC and EJH has generated more than 20 correspondences 2 satisfy SEC's numerous reviews & questions about EJH registration. The final SEC-satisfied registration for the IPO (dated 5/13) shows:
1) 2,000,000 registered members
2) 835,000 orders FY 2020 ( 6/30/20)
3) 862,000 orders 1H 2021 (12/31/2020)
4) Revenue: $51.1M FY 2019, $46.2M FY 2020, $44.1M 1H 2021.
5) NET INCOME: $10.2M 2019, $5.6M 2020, $8.9M 1H 2021.
EJH REV&PROFIT GROWTH IS PHENOMENAL!!?????? I see HUGE POTENTIAL $80-$100/share in couple years. See chart. Check edgar site if you're interest [/img]in reading all 49 SEC Filings sec.gov/edgar/browse/?CIK=1 http://investorshub.advfn.com/uimage/uploads/2021/10/25/TPQGGVAUVTAMW.JPG">http://investorshub.advfn.com/uimage/uploads/2021/10/25/TPQGGVAUVTAMW.JPG" />[/img]
Rafun - I'm so glad I got out AMRN with a little profit.
This is JUST SO WRONG and SO blatantly vain self-congratulatory from the company. The entire BOD must be fired before investors can see some positive signs for SP. GLTA suffering longs! I understand your pain.
OT to FFS - I would appreciate your TA look at this company, METX. I think it has HUGE potential to double or more b4 year end.
https://finviz.com/quote.ashx?t=METX&ty=c&ta=1&p=d
TIA!
I like the new Zovio's LTI plan VERY MUCH!
https://fintel.io/doc/sec-zovio-inc-1305323-8k-2021-june-03-18781-7472
Wish AMRN Executive's compensation plan was similar to Zovio (ZVO) LTI.
https://fintel.io/doc/sec-zovio-inc-1305323-8k-2021-june-03-18781-7472
CSU and Fullstack Partnership https://www.businesswire.com/news/home/20210602005589/en/
This is very positive catalyst news about CSU partnership with Fullstack. Hope SP will reach $2.50+ this week. I'm now a GREEN 30K-share bag holder. I can wait with quite a positive up trend until August for Q2 ER to see what I will do next with ZVO.
4/21/21 Amarin and Healthnet agrre on extension 4/21/21
Compliment from ST steven1x
https://charts.stocktwits.com/production/original_319385818.png
How about BOTH and then a R/S to bring down the O/S. LOL! The incoming CEO can be a quick & BIG Hero by just buying 10K shares today.
@Lizzy please see Study's post 330830
@Study Thanks for the clarification.
Rafun and all: Does anyone see anything today that rafun mentioned? TIA
If one can trust some posts on cafepharma message board, one may find Amarin Sales Reps'posts depressing http://www.cafepharma.com/boards/forums/amarin.839/ LOL=)
Kiwi That's great. Amarin may get some free ad time for VASCEPA if the "journalist" wants to present a balanced view with PRO's and CON's. Let's hope so. LOL=)
Kiwi, From rafun schinn@good4utah.com
REDUCE-IT latest twit and retwitted bt Dr. Bhatt JUST NOW!
Fantastic @WesternU Cardiology Grand Rounds this morning with @DLBHATTMD pic.twitter.com/4q6pL4Uwmf
— Dr Sabe De (@drsabede) February 1, 2021
Dr. Bhatt's latest twit just now.
VASCEPA (Icosapent Ethyl) Receives Further Inclusions in Guidelines from International Medical Societies for its ... https://t.co/1Rbv7RBUmY #cardiotwitter @mmillermd1 @CBallantyneMD @gabrielsteg @CMichaelGibson @EliotBrinton @jctardif_mhi @cpcannon
— Dr. Deepak L. Bhatt (@DLBHATTMD) January 28, 2021
I'v been shorting it since PM at $25/share down to $19/share for a total of 10k shares. I'm now just waiting to close when the crazy mood is OVER, hopefully b4 4:00PM today. :=)
Pharmacydude - The Review!! Congratulation for such great work! I'm sure you must be proud and AMRN stakeholders appreciate your effort greatly!
https://thereview.ca/2021/01/12/hawkesbury-pharmacist-receives-accolades-for-paper-on-promising-drug-to-treat-covid-19-symptoms/
DTG Hikma did talk about AMRN with one slide. They just mentioned Amarin law suit and Hikma action to dismiss the law suit. Hope AMRN presentation at 2:00PM will get more into the gV and legal plan of action against Hikma's dismissal request
HK EXCELLENT job! Thank you for taking the time and effort to help us understand the important of this ANMRN's newly granted patent
Here's the latest tweet from Dr. Bhatt on REDUCE-IT.
REDUCE-IT REVASC presented at @SCAI by @benpeterson71 now published in @CircAHA showing very large reductions in elective/urgent/emergent PCI/CABG with icosapent ethyl. #cardiotwitter #cardiology #prevention @mmillermd1 @CBallantyneMD @duanepinto @CMichaelGibson @BrighamFellows https://t.co/gcj7t4RK6r
— Dr. Deepak L. Bhatt (@DLBHATTMD) January 5, 2021
By now ALL longs should get used to the fact that every month JT and other Officers will get their RSU options and they will sell a fixed amount of shares to pay for taxes. JT did one exception in Nov 2020 with his "buying" 182,595? shares with his own $$$ after exercising his 750,000 shares option at $3.4 and sold 567,405 shares. I do not blame him and others for what they must do to keep their tax and finance in order. C'est La Vie. Deal with it and quit bitching every month about it. You can always sell your AMRN holding and quit your whining. Here's JT insider activity https://fintel.io/n/us/amrn/thero-john-f
12/28/20 UPDATED REDUCE-IT "ACC Reduction of Cardiovascular Events With Icosapent Ethyl–Intervention Trial - REDUCE-IT"
https://www.acc.org/latest-in-cardiology/clinical-trials/2018/11/08/22/48/reduce-it?utm_medium=social&utm_source=twitter_post&utm_campaign=twitter_post
L3 regardless how complicated it is to provide the "APPROVED therapy", IT IS the APPROVED one. My point is V is still quite a long way from being APPROVED (if it ever happens) for covid-19 therapy. So the news and all the VERY POSITIVE technical analysis and presentations HAVE NO effect to SP according to WS reactions so far.
Based on this latest WSJ article (12/27), I figure we can forget about V's covid-19 potential for a while. https://www.wsj.com/articles/highly-touted-monoclonal-antibody-therapies-sit-unused-in-hospitals-11609087364?mod=hp_lead_pos6. Here's some text if you have no access to wsj. Happy New Year!!